Davenport & CO LLC Quotient LTD Transaction History

Davenport & CO LLC

$16.8 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Oct 11, 2022	SELL	$0.16 - $0.31 $110 - $213	-690 Reduced 4.47%	14,730 $2,000
Q2 2022 Jul 18, 2022	SELL	$0.24 - $1.2 $296 - $1,482	-1,235 Reduced 7.42%	15,420 $4,000
Q4 2021 Feb 10, 2022	SELL	$1.89 - $3.12 $34,965 - $57,720	-18,500 Reduced 52.62%	16,655 $43,000
Q3 2021 Oct 14, 2021	SELL	$2.34 - $3.77 $11,700 - $18,850	-5,000 Reduced 12.45%	35,155 $82,000
Q1 2021 Apr 28, 2021	SELL	$3.57 - $6.2 $119,773 - $208,010	-33,550 Reduced 45.52%	40,155 $148,000
Q4 2020 Jan 13, 2021	SELL	$4.4 - $7.32 $24,200 - $40,260	-5,500 Reduced 6.94%	73,705 $384,000
Q3 2020 Oct 15, 2020	SELL	$4.38 - $8.35 $66,576 - $126,920	-15,200 Reduced 16.1%	79,205 $407,000
Q2 2020 Jul 28, 2020	SELL	$3.64 - $9.26 $38,402 - $97,693	-10,550 Reduced 10.05%	94,405 $699,000
Q1 2020 May 05, 2020	BUY	$2.54 - $9.38 $228,485 - $843,777	89,955 Added 599.7%	104,955 $415,000
Q4 2019 Jan 22, 2020	BUY	$7.07 - $9.51 $106,050 - $142,650	15,000 New	15,000 $143,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.